Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

CE earnings analysis

Filed May 6, 2026 · Our reading of the company's report

The latest report

Celanese Corporation reported Q1 2026 earnings that reflected a slight decline in revenue compared to the previous year, primarily driven by decreased sales in the Acetyl Chain segment. However, operating profit saw a…

Read full summary

Celanese Corporation reported Q1 2026 earnings that reflected a slight decline in revenue compared to the previous year, primarily driven by decreased sales in the Acetyl Chain segment. However, operating profit saw a significant increase due to a sizable gain from the sale of the Micromax® business. Free cash flow is expected to improve following management's operational enhancements and updated guidance for cash flows, despite challenges in raw material pricing and market demand.

Read the original on SEC.gov

From revenue to operating profit

Where each $100 of revenue went in this report.

Of every $100 of revenue Cost of sales $80 Operating expenses $11 Left as operating profit $9

Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.

Where revenue came from

The business segments reported by the company.

Engineered Materials 55.9% Acetyl Chain 44.1%

Shares of the segments disclosed in this filing, largest first.

Reported figures

Earnings per share
$0.85

What stood out

  • Revenue of $2.34B, Beat Estimates

    Actual revenue for Q1 2026 was $2.34 billion, exceeding estimates of $2.33 billion by 0.3%.

  • Operating Profit Increased 30%

    Operating profit rose to $214 million, up from $165 million in the prior year, a 30% increase.

  • Free Cash Flow Reversal

    Free cash flow guidance increased to $700-$800 million for the year following a significant operational focus.

  • Engineered Materials Segment Growth

    The Engineered Materials segment revenue increased by 3% to $1.32 billion due to favorable exchange rates.

  • Strong Cash Position

    Cash and cash equivalents rose to $1.76 billion from $1.26 billion at the end of 2025, an increase of $495 million.

  • Equity Earnings Growth

    Equity in net earnings of affiliates increased by 59% to $35 million compared to $22 million in Q1 2025.

What to watch

  • Decline in Acetyl Chain Revenue

    Revenue for the Acetyl Chain segment fell by 7.2% to $1.04 billion due to lower global demand and pricing pressures.

  • Continued High Raw Material Costs

    Rising volatility in raw material prices continues to pose a risk to margins, especially in the Acetyl Chain.

  • Weak Market Demand

    Management indicated persistent weakness in end-market demand across various sectors, including automotive and construction.

Management's outlook

Free cash flow guidance updated to $700-$800 million for FY 2026; outlook for EPS in Q2 ranges from $2.00 to $2.40.

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.